DOCSLIB.ORG

A P53-Dependent S-Phase Checkpoint Helps to Protect Cells from DNA Damage in Response to Starvation for Pyrimidine Nucleotides

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
A P53-Dependent S-Phase Checkpoint Helps to Protect Cells from DNA Damage in Response to Starvation for Pyrimidine Nucleotides Proc. Natl. Acad. Sci. USA Vol. 95, pp. 14775–14780, December 1998 Cell Biology A p53-dependent S-phase checkpoint helps to protect cells from DNA damage in response to starvation for pyrimidine nucleotides (Li-Fraumeni cellsyREF52 cellsygene amplificationycell cycle arrestyG1 checkpoint) MUNNA L. AGARWAL,ARCHANA AGARWAL,WILLIAM R. TAYLOR,OLGA CHERNOVA,YOGESH SHARMA, AND GEORGE R. STARK* Department of Molecular Biology, Lerner Research Institute, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195 Contributed by George R. Stark, October 9, 1998 ABSTRACT Normal mammalian cells arrest primarily in mechanisms that do not involve broken DNA (16). Paulson et G1 in response to N-(phosphonacetyl)-L-aspartate (PALA), al. (23) have shown that, in the absence of a functional p53 which starves them for pyrimidine nucleotides, and do not pathway, PALA treatment of tumor cells leads to DNA generate or tolerate amplification of the CAD gene, which damage and thus to CAD gene amplification. Furthermore, in confers resistance to PALA. Loss of p53, accompanied by loss some cells the induction of p53 and associated G1 arrest are of G1 arrest, permits CAD gene amplification and the conse- defective in response to PALA but normal in response to quent formation of PALA-resistant colonies. We have found g-radiation (24), suggesting that there are distinct and sepa- rat and human cell lines that retain wild-type p53 but have lost rable pathways of p53 activation in response to these different the ability to arrest in G1 in response to PALA. However, these stimuli. In this report, we describe the responses of several cell cells still fail to give PALA-resistant colonies and are pro- lines to pyrimidine nucleotide depletion or radiation-induced tected from DNA damage through the operation of a second DNA damage. All of these lines have functional, wild-type p53 checkpoint that arrests them reversibly within S-phase. This and are not permissive for gene amplification. However, S-phase arrest, unmasked in the absence of the G1 checkpoint, instead of accumulating in G1 after treatment with PALA, two is dependent on p53 and independent of p21ywaf1. of the cell lines arrest within S-phase. We suggest that activa- tion of p53 by pyrimidine starvation causes a stable and Normal mammalian cells maintain genomic integrity through reversible arrest in G1 and also within S-phase, thus regulating controls that regulate their ability to progress through the cell genomic stability at more than one point of the cell cycle. cycle when they encounter environmental stress (1, 2). When these controls are deranged, the result is genomic instability, MATERIALS AND METHODS a hallmark of neoplasia. The tumor suppressor protein p53, commonly inactivated in tumors, is a major regulator of cell Cell Lines and Culture Conditions. The MDAH041 post- cycle progression in response to DNA damage or arrest of crisis cell line, kindly provided by M. Tainsky (25), was derived DNA synthesis (3–5). The signals generated by these stresses from the fibroblasts of a patient with Li-Fraumeni syndrome. lead to an increase in the level of p53 protein and also stimulate There is a frame shift mutation in one p53 allele at codon 184, its ability to activate transcription, leading to cell cycle arrest and the normal p53 allele has been lost during in vitro y propagation (20). Normal human WI38 fibroblasts were ob- in both G1 (6–8) and G2 M (9, 10). An important transcrip- tional target of p53 is the cyclin-dependent kinase inhibitor tained from the American Type Culture Collection. TR9-7 p21ywaf1 (11), which helps to mediate cell cycle responses to cells, expressing wild-type p53 under the control of a tetracy- DNA damage (12–14). In primary human fibroblasts, the cline-regulated promoter, were derived from MDAH041 cells (17). Cell lines containing a neo marker were grown in the p53-mediated cell cycle arrest in response to DNA damage is m y irreversible (15). However, overexpression of p53 without presence of G418 (600 g ml). Early passage p53-null and y p21-null mouse embryo fibroblasts (MEFs) were provided by DNA damage leads to reversible arrest in both G1 and G2 M (16–18). L. Donehower and G. Hannon, respectively. Normal human By using p53-null mouse or human cells, or by using the E6 fibroblast (LF1) cells and their p21-null derivative (H07.2–1) protein of human papilloma virus 16 to inactivate p53, it was were gifts of J. Sedivy (26). Low passage primary rat embryo shown that cells become permissive for CAD gene amplifica- fibroblast (REF) cells were provided by Andrei Gudkov (University of Illinois, Chicago) and REF52 cells were as tion and thus N-(phosphonacetyl)-L-aspartate (PALA) resis- tance when p53 is absent (19–21). In contrast, cells with intact described by Franza et al. (27). All cells were grown in 10% CO2 in DMEM, supplemented with 10% fetal bovine serum. p53 arrest stably, predominantly in G1, and do not form resistant colonies in PALA (19, 20). These observations reveal PALA Selections. PALA (NSC224131), an inhibitor of the aspartate transcarbamylase activity of the multifunctional that PALA induces a p53-dependent cell cycle arrest in G1, thus suppressing gene amplification and genetic instability CAD enzyme, was obtained from the Drug Synthesis and (16). In rodent cells, CAD gene amplification is the only Chemistry Branch, Developmental Therapeutics Program, mechanism observed for PALA resistance, but human cells Division of Cancer Treatment, National Cancer Institute, become resistant to PALA through additional mechanisms Bethesda, MD. Treatments of cells with PALA were as described by Agarwal et al. (28). For each cell line or strain, the including but not limited to CAD gene amplification (22). ID was determined and selections of 2 3 105 cells per 10-cm In normal human fibroblasts deprived of pyrimidine nucle- 50 plate were done in the presence of 10% (volyvol) dialyzed fetal otides by PALA, wild-type p53 mediates G1 arrest through 3 calf serum, using PALA at 3 ID50 (29). The selective The publication costs of this article were defrayed in part by page charge Abbreviations: PALA, N-(phosphonacetyl)-L-aspartate; REF, rat em- payment. This article must therefore be hereby marked ‘‘advertisement’’ in bryo fibroblast; HPRT, hypoxanthine phosphoribosyl transferase; accordance with 18 U.S.C. §1734 solely to indicate this fact. MEF, mouse embryo fibroblast; 6TG, 6-thioguanine. © 1998 by The National Academy of Sciences 0027-8424y98y9514775-6$2.00y0 *To whom reprint requests should be addressed. e-mail: starkg@ PNAS is available online at www.pnas.org. cesmtp.ccf.org. 14775 Downloaded by guest on October 2, 2021 14776 Cell Biology: Agarwal et al. Proc. Natl. Acad. Sci. USA 95 (1998) medium was changed every 4–5 days until colonies of 100–200 cells were observed, typically in 3–4 weeks. Western and Northern Analyses. Total cellular protein was isolated by lysing cells in 20 mM TriszHCl, pH 7.5, 2% (wtyvol) SDS, 2 mM benzamidine, and 0.2 mM phenylmethanesulfonyl fluoride. Protein concentrations were determined by the Brad- ford method (Bio-Rad). Proteins (25 mgylane) were separated by SDS-10% PAGE and electroblotted to polyvinylidene difluoride membranes (Stratagene; ref. 30). After transfer, the gels were stained with Coomassie blue (Sigma) to verify equal loading. The membranes were probed with mAb DO-1 (Santa Cruz Biotech), directed against p53, and bound antibody was detected by enhanced chemiluminescence (Amersham). Northern analysis: Total RNA was extracted with the Trizol reagent (GIBCOyBRL) as specified by the manufacturer. Analysis was performed as described by Sambrook et al. (31). Cell Cycle Analysis. The DNA content of trypsinized cells was determined by staining with propidium iodide, using a Cycletest kit (Becton Dickinson). Cell cycle distribution was determined by using a FACScan instrument (Becton Dickin- FIG. 1. Induction of p53 and p21ywaf1 by PALA. (A) Cells were son), CELL FIT software, and an HP340 Series 9000 Worksta- treated for 4 days with 0.5 mM PALA, and p53 was detected by tion (Hewlett–Packard). Dead cells were gated out by using Western analysis, using the DO-1 antibody, which was detected by pulse processing. enhanced chemiluminescence. (B) Levels of p21 mRNA. Total RNA Measurement of DNA Synthesis. For tritium labeling, C11 was separated by electrophoresis in an agarose gel and transferred to and MDAH041 cells were grown in 6-well plates and treated a nylon membrane. p21 mRNA was detected with a specific human 3 m 3 with PALA at 3 ID50. After 3 days, 5 Ci of H-labeled cDNA probe. Glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) thymidine was added to each well, and the cells were incubated served as loading control. for 2 hr more. After a trichloracetic acid wash, 0.5 ml of 2 M perchloric acid was added to each well at 60°C for 30 min. The However, TR9-7 cells plus tetracycline and C11 cells retain resulting solution was transferred to scintillant and 3H incor- many other p53-dependent responses of normal human fibro- poration was determined. The residue was dissolved in alkali blast cell strains, in contrast with their p53-null MDAH041 parents. Similarly, the rat cell line REF52, which has wild-type for protein determination. For BrdUrd incorporation, cells 3 p53, retains many normal responses characteristic of REF cell grown on coverslips were treated with PALA (3 ID50) and strains. For example, none of these cell lines exhibit gene were incubated for an additional 4 hr in medium containing 10 m amplification in selective concentrations of PALA (refs. 29 and M BrdUrd. The incorporation of BrdUrd into DNA was 34 and data presented below), TR9-7 (plus tetracycline), and determined by immunostaining (Amersham). y REF52 cells arrest normally at the G1 S boundary in response to DNA damage (see below), and TR9-7 and C11 cells retain y RESULTS the normal p53-dependent arrest at G2 M in response to inhibition of DNA synthesis (5).
Load more

Recommended publications
  • DNA Damage Checkpoint Dynamics Drive Cell Cycle Phase Transitions
    bioRxiv preprint doi: https://doi.org/10.1101/137307; this version posted August 4, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. DNA damage checkpoint dynamics drive cell cycle phase transitions Hui Xiao Chao1,2, Cere E. Poovey1, Ashley A. Privette1, Gavin D. Grant3,4, Hui Yan Chao1, Jeanette G. Cook3,4, and Jeremy E. Purvis1,2,4,† 1Department of Genetics 2Curriculum for Bioinformatics and Computational Biology 3Department of Biochemistry and Biophysics 4Lineberger Comprehensive Cancer Center University of North Carolina, Chapel Hill 120 Mason Farm Road Chapel Hill, NC 27599-7264 †Corresponding Author: Jeremy Purvis Genetic Medicine Building 5061, CB#7264 120 Mason Farm Road Chapel Hill, NC 27599-7264 [email protected] ABSTRACT DNA damage checkpoints are cellular mechanisms that protect the integrity of the genome during cell cycle progression. In response to genotoxic stress, these checkpoints halt cell cycle progression until the damage is repaired, allowing cells enough time to recover from damage before resuming normal proliferation. Here, we investigate the temporal dynamics of DNA damage checkpoints in individual proliferating cells by observing cell cycle phase transitions following acute DNA damage. We find that in gap phases (G1 and G2), DNA damage triggers an abrupt halt to cell cycle progression in which the duration of arrest correlates with the severity of damage. However, cells that have already progressed beyond a proposed “commitment point” within a given cell cycle phase readily transition to the next phase, revealing a relaxation of checkpoint stringency during later stages of certain cell cycle phases.
    [Show full text]
  • Mitosis Vs. Meiosis
    Mitosis vs. Meiosis In order for organisms to continue growing and/or replace cells that are dead or beyond repair, cells must replicate, or make identical copies of themselves. In order to do this and maintain the proper number of chromosomes, the cells of eukaryotes must undergo mitosis to divide up their DNA. The dividing of the DNA ensures that both the “old” cell (parent cell) and the “new” cells (daughter cells) have the same genetic makeup and both will be diploid, or containing the same number of chromosomes as the parent cell. For reproduction of an organism to occur, the original parent cell will undergo Meiosis to create 4 new daughter cells with a slightly different genetic makeup in order to ensure genetic diversity when fertilization occurs. The four daughter cells will be haploid, or containing half the number of chromosomes as the parent cell. The difference between the two processes is that mitosis occurs in non-reproductive cells, or somatic cells, and meiosis occurs in the cells that participate in sexual reproduction, or germ cells. The Somatic Cell Cycle (Mitosis) The somatic cell cycle consists of 3 phases: interphase, m phase, and cytokinesis. 1. Interphase: Interphase is considered the non-dividing phase of the cell cycle. It is not a part of the actual process of mitosis, but it readies the cell for mitosis. It is made up of 3 sub-phases: • G1 Phase: In G1, the cell is growing. In most organisms, the majority of the cell’s life span is spent in G1. • S Phase: In each human somatic cell, there are 23 pairs of chromosomes; one chromosome comes from the mother and one comes from the father.
    [Show full text]
  • The Cell Cycle Coloring Worksheet
    Name: Date: Period: The Cell Cycle Coloring Worksheet Label the diagram below with the following labels: Anaphase Interphase Mitosis Cell division (M Phase) Interphase Prophase Cytokinesis Interphase S-DNA replication G1 – cell grows Metaphase Telophase G2 – prepares for mitosis Then on the diagram, lightly color the G1 phase BLUE, the S phase YELLOW, the G2 phase RED, and the stages of mitosis ORANGE. Color the arrows indicating all of the interphases in GREEN. Color the part of the arrow indicating mitosis PURPLE and the part of the arrow indicating cytokinesis YELLOW. M-PHASE YELLOW: GREEN: CYTOKINESIS INTERPHASE PURPLE: TELOPHASE MITOSIS ANAPHASE ORANGE METAPHASE BLUE: G1: GROWS PROPHASE PURPLE MITOSIS RED:G2: PREPARES GREEN: FOR MITOSIS INTERPHASE YELLOW: S PHASE: DNA REPLICATION GREEN: INTERPHASE Use the diagram and your notes to answer the following questions. 1. What is a series of events that cells go through as they grow and divide? CELL CYCLE 2. What is the longest stage of the cell cycle called? INTERPHASE 3. During what stage does the G1, S, and G2 phases happen? INTERPHASE 4. During what phase of the cell cycle does mitosis and cytokinesis occur? M-PHASE 5. During what phase of the cell cycle does cell division occur? MITOSIS 6. During what phase of the cell cycle is DNA replicated? S-PHASE 7. During what phase of the cell cycle does the cell grow? G1,G2 8. During what phase of the cell cycle does the cell prepare for mitosis? G2 9. How many stages are there in mitosis? 4 10. Put the following stages of mitosis in order: anaphase, prophase, metaphase, and telophase.
    [Show full text]
  • Working on Genomic Stability: from the S-Phase to Mitosis
    G C A T T A C G G C A T genes Review Working on Genomic Stability: From the S-Phase to Mitosis Sara Ovejero 1,2,3,* , Avelino Bueno 1,4 and María P. Sacristán 1,4,* 1 Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Universidad de Salamanca-CSIC, Campus Miguel de Unamuno, 37007 Salamanca, Spain; [email protected] 2 Institute of Human Genetics, CNRS, University of Montpellier, 34000 Montpellier, France 3 Department of Biological Hematology, CHU Montpellier, 34295 Montpellier, France 4 Departamento de Microbiología y Genética, Universidad de Salamanca, Campus Miguel de Unamuno, 37007 Salamanca, Spain * Correspondence: [email protected] (S.O.); [email protected] (M.P.S.); Tel.: +34-923-294808 (M.P.S.) Received: 31 January 2020; Accepted: 18 February 2020; Published: 20 February 2020 Abstract: Fidelity in chromosome duplication and segregation is indispensable for maintaining genomic stability and the perpetuation of life. Challenges to genome integrity jeopardize cell survival and are at the root of different types of pathologies, such as cancer. The following three main sources of genomic instability exist: DNA damage, replicative stress, and chromosome segregation defects. In response to these challenges, eukaryotic cells have evolved control mechanisms, also known as checkpoint systems, which sense under-replicated or damaged DNA and activate specialized DNA repair machineries. Cells make use of these checkpoints throughout interphase to shield genome integrity before mitosis. Later on, when the cells enter into mitosis, the spindle assembly checkpoint (SAC) is activated and remains active until the chromosomes are properly attached to the spindle apparatus to ensure an equal segregation among daughter cells.
    [Show full text]
  • S-Phase Entry, Activation of E2F-Responsive Genes, and Apoptosis
    Proc. Natl. Acad. Sci. USA Vol. 92, pp. 5436-5440, June 1995 Medical Sciences Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis (tumor supressor gene/cell cycle control/programmed cell death) ALEXANDRU ALMASAN*tt, YUXIN YIN*t§, RUTH E. KELLY*, EVA Y.-H. P. LEES, ALLAN BRADLEYII, WEIWEI LI**, JOSEPH R. BERTINO**, AND GEOFFREY M. WAHL*tt *Gene Expression Laboratory, The Salk Institute, 10010 North Torrey Pines Road, La Jolla, CA 92037; tCenter for Molecular Medicine and Institute of Biotechnology, The University of Texas Health Science Center at San Antonio, San Antonio, TX 78284; I'Department of Molecular and Human Genetics and Howard Hughes Medical Institute, Baylor College of Medicine, Houston, TX 77030; and **Program for Molecular Pharmacology and Therapeutics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021 Communicated by Leslie E. Orgel, The Salk Institute for Biological Studies, San Diego, CA, January 24, 1995 (received for review December 12, 1994) ABSTRACT The retinoblastoma susceptibility gene (Rb) thymidylate synthase (TS) and other genes necessary for entry participates in controlling the G1/S-phase transition, pre- into and progression through S phase (10, 14). sumably by binding and inactivating E2F transcription acti- The data obtained from studies with viral oncoproteins vator family members. Mouse embryonic fibroblasts (MEFs) suggest that Rb protein acts by sequestering essential factors with no, one, or two inactivated Rb genes were used to determine required for G1/S progression. However, each of these onco- the specific contributions of Rb protein to cell cycle progres- proteins binds other cellular factors such as the Rb-related sion and gene expression.
    [Show full text]
  • Regulation of the Cell Cycle and DNA Damage-Induced Checkpoint Activation
    RnDSy-lu-2945 Regulation of the Cell Cycle and DNA Damage-Induced Checkpoint Activation IR UV IR Stalled Replication Forks/ BRCA1 Rad50 Long Stretches of ss-DNA Rad50 Mre11 BRCA1 Nbs1 Rad9-Rad1-Hus1 Mre11 RPA MDC1 γ-H2AX DNA Pol α/Primase RFC2-5 MDC1 Nbs1 53BP1 MCM2-7 53BP1 γ-H2AX Rad17 Claspin MCM10 Rad9-Rad1-Hus1 TopBP1 CDC45 G1/S Checkpoint Intra-S-Phase RFC2-5 ATM ATR TopBP1 Rad17 ATRIP ATM Checkpoint Claspin Chk2 Chk1 Chk2 Chk1 ATR Rad50 ATRIP Mre11 FANCD2 Ubiquitin MDM2 MDM2 Nbs1 CDC25A Rad50 Mre11 BRCA1 Ub-mediated Phosphatase p53 CDC25A Ubiquitin p53 FANCD2 Phosphatase Degradation Nbs1 p53 p53 CDK2 p21 p21 BRCA1 Ub-mediated SMC1 Degradation Cyclin E/A SMC1 CDK2 Slow S Phase CDC45 Progression p21 DNA Pol α/Primase Slow S Phase p21 Cyclin E Progression Maintenance of Inhibition of New CDC6 CDT1 CDC45 G1/S Arrest Origin Firing ORC MCM2-7 MCM2-7 Recovery of Stalled Replication Forks Inhibition of MCM10 MCM10 Replication Origin Firing DNA Pol α/Primase ORI CDC6 CDT1 MCM2-7 ORC S Phase Delay MCM2-7 MCM10 MCM10 ORI Geminin EGF EGF R GAB-1 CDC6 CDT1 ORC MCM2-7 PI 3-Kinase p70 S6K MCM2-7 S6 Protein Translation Pre-RC (G1) GAB-2 MCM10 GSK-3 TSC1/2 MCM10 ORI PIP2 TOR Promotes Replication CAK EGF Origin Firing Origin PIP3 Activation CDK2 EGF R Akt CDC25A PDK-1 Phosphatase Cyclin E/A SHIP CIP/KIP (p21, p27, p57) (Active) PLCγ PP2A (Active) PTEN CDC45 PIP2 CAK Unwinding RPA CDC7 CDK2 IP3 DAG (Active) Positive DBF4 α Feedback CDC25A DNA Pol /Primase Cyclin E Loop Phosphatase PKC ORC RAS CDK4/6 CDK2 (Active) Cyclin E MCM10 CDC45 RPA IP Receptor
    [Show full text]
  • Human P14arf-Mediated Cell Cycle Arrest Strictly Depends on Intact P53 Signaling Pathways
    Oncogene (2002) 21, 3207 ± 3212 ã 2002 Nature Publishing Group All rights reserved 0950 ± 9232/02 $25.00 www.nature.com/onc Human p14ARF-mediated cell cycle arrest strictly depends on intact p53 signaling pathways H Oliver Weber1,2, Temesgen Samuel1,3, Pia Rauch1 and Jens Oliver Funk*,1 1Laboratory of Molecular Tumor Biology, Department of Dermatology, University of Erlangen-Nuremberg, 91052 Erlangen, Germany; 2Regulation of Cell Growth Laboratory, National Cancer Institute, Frederick, Maryland, MD 21702-1201, USA The tumor suppressor ARF is transcribed from the INK4a/ 4 and 6 activities, thus leading to decreased phosphor- ARF locus in partly overlapping reading frames with the ylation of RB and to G1 arrest. Cells that are de®cient CDK inhibitor p16Ink4a. ARF is able to antagonize the for RB are resistant to p16Ink4a-mediated cell cycle MDM2-mediated ubiquitination and degradation of p53, arrest (Sherr and Roberts, 1995; Weinberg, 1995). leading to either cell cycle arrest or apoptosis, depending on ARF is also a cell cyle inhibitor. It does not directly the cellular context. However, recent data point to inhibit CDKs but interferes with the function of additional p53-independent functions of mouse p19ARF. MDM2 to destabilize p53. ARF may be activated by Little is known about the dependency of human p14ARF aberrant activation of oncoproteins such as Ras function on p53 and its downstream genes. Therefore, we (Palmero et al., 1998), c-myc (Zindy et al., 1998), analysed the mechanism of p14ARF-induced cell cycle arrest E1A (de Stanchina et al., 1998), Abl (Radfar et al., in several human cell types.
    [Show full text]
  • P14arf Expression Increases Dihydrofolate Reductase Degradation and Paradoxically Results in Resistance to Folate Antagonists in Cells with Nonfunctional P53
    [CANCER RESEARCH 64, 4338–4345, June 15, 2004] p14ARF Expression Increases Dihydrofolate Reductase Degradation and Paradoxically Results in Resistance to Folate Antagonists in Cells with Nonfunctional p53 Pellegrino G. Magro,1,2 Angelo J. Russo,1,2 Wei-Wei Li,2 Debabrata Banerjee,3 and Joseph R. Bertino3 1Joan and Sanford I. Weill Graduate School of Medical Sciences of Cornell University, New York, New York; 2Memorial Sloan Kettering Cancer Center, New York, New York; and 3The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, New Brunswick, New Jersey ABSTRACT Although much is known about the function of ARF in the p53 pathway, less is known about its functions in human tumor growth and ARF The p14 protein, the product of an alternate reading frame of the chemosensitivity independently of its regulation of p53 via binding to INK4A/ARF locus on human chromosome 9p21, disrupts the ability of MDM2. Mouse embryonic fibroblasts expressing E1A and exogenous MDM2 to target p53 for proteosomal degradation and causes an increase ARF are more sensitive to killing by doxorubicin than their normal in steady-state p53 levels, leading to a G1 and G2 arrest of cells in the cell cycle. Although much is known about the function of p14ARF in the p53 counterparts that only express E1A (7). Alterations in the INK4A/ pathway, not as much is known about its function in human tumor growth ARF locus reduce p53 induction and cytotoxicity of cyclophospha- and chemosensitivity independently of up-regulation of p53 protein levels. mide in mouse lymphomas (16). Also, recombinant adenovirus-me- To learn more about its effect on cellular proliferation and chemoresis- diated p14ARF overexpression sensitizes MCF-7 breast cancer cells to tance independent of p53 up-regulation, human HT-1080 fibrosarcoma cisplatin (17).
    [Show full text]
  • Cyclin-Dependent Kinase 7 (CDK7) Expression in Human Hepatocellular Carcinoma: Association with HCC Progression, Prognosis and Cell Proliferative Capacity
    479 Original Article Cyclin-dependent kinase 7 (CDK7) expression in human hepatocellular carcinoma: association with HCC progression, prognosis and cell proliferative capacity Zheran Liu1,2#, Dajiao Liu1#, Rongrong Zhong2, Qiuyun Su1, Tiancheng Zhao3, Fen Fu4, Jinsheng Liu5, Derong Xu1, Changqing Zeng5 1School of Public Health, Nanchang University, Nanchang 330031, China; 2Queen Mary School, Medical College of Nanchang University, Nanchang 330031, China; 3The School of General Studies, Columbia University in the City of New York, New York, NY, USA; 4The Second Affiliated Hospital of Nanchang University, Nanchang 330031, China; 5Provincial College of Clinical Medicine, Fujian Provincial Hospital of Fujian Medical University, Fuzhou 350001, China Contributions: (I) Conception and design: D Xu; (II) Administrative support: C Zeng; (III) Provision of study materials or patients: D Liu; (IV) Collection and assembly of data: Z Liu; (V) Data analysis and interpretation: Z Liu; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. #These authors contributed equally to this work. Correspondence to: Derong Xu. School of Public Health, Nanchang University, Nanchang 330031, China. Email: [email protected]; Changqing Zeng. Provincial College of Clinical Medicine, Fujian Provincial Hospital of Fujian Medical University, Fuzhou 350001, China. Email: [email protected]. Background: Hepatocellular carcinoma (HCC) is one of the most common malignancies in the world and contributes to a high cancer mortality globally. The multistep progression of HCC is highly related to the activation of oncogenes and the deactivation of cancer suppressor genes. The cyclin-dependent kinase 7 (CDK7) gene is responsible for maintaining a normal cell cycle, acting as a gatekeeper, and plays an important part in RNA transcription.
    [Show full text]
  • Role for E2F in DNA Damage-Induced Entry of Cells Into S Phase1
    ICANCERRESEARCH57, 3640-3643. September I. 19971 Advances in Brief Role for E2F in DNA Damage-induced Entry of Cells into S Phase1 Yinyin Huang, Takatoshi Ishiko, Shuji Nakada, Taiju Utsugisawa, Tomohisa Kato, and Zhi-Min Yuan2 Division of Cancer Pharmacology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115 Abstract Materials and Methods Mammalian cells respond to ionizing radiation (IR) with transient cell Cell Culture and Cell Cycle Analysis. HumanHL-60cells weregrownin cycle arrest and induction of apoptosis. Here we show that IR increases RPM! 1640 containing 10% heat-inactivated fetal bovine scram, 1 mM L the expression of the E2F-1 transcription factor and the entry of cells into glutamine, 100 units/mI penicillin, and 100 @zg/mlstreptomycin. The null S phase. E2F-1 transactivation function is inhibited by cydlinA-kinaseto pCMV-HA vector and pCMV-HA-DP-l'27410 deletion mutant were intro ensure orderly progression through S phase. However, in contrast to duced into HL-60 cells by electroporation. Stable lines were established by proliferating cells, IR treatment results in down-regulation of cydin A- selection in G418. Irradiation was performed at room temperature in a Gam kinase. Expression of a dominant negative form of the E2F heterodimeric macell 1000 (Atomic Energy of Canada, Ottawa, Canada) with a ‘37Cssource partner DP-1 confirmed the involvement of E2F in IR-induced S-phase emitting a fixed dose of 13.3 Gy/min. DNA content was assessed by staining entry. These fmdings also support opposing signals involving the induc ethanol-fixed cells with propidium iodide and monitoring by FACScan.
    [Show full text]
  • CDK Regulation of Meiosis: Lessons from S. Cerevisiae and S. Pombe
    G C A T T A C G G C A T genes Review CDK Regulation of Meiosis: Lessons from S. cerevisiae and S. pombe Anne M. MacKenzie and Soni Lacefield * Department of Biology, Indiana University, 1001 E. Third Street, Bloomington, IN 47405, USA; [email protected] * Correspondence: [email protected]; Tel.: +1-812-856-2429 Received: 16 May 2020; Accepted: 26 June 2020; Published: 29 June 2020 Abstract: Meiotic progression requires precise orchestration, such that one round of DNA replication is followed by two meiotic divisions. The order and timing of meiotic events is controlled through the modulation of the phosphorylation state of proteins. Key components of this phospho-regulatory system include cyclin-dependent kinase (CDK) and its cyclin regulatory subunits. Over the past two decades, studies in budding and fission yeast have greatly informed our understanding of the role of CDK in meiotic regulation. In this review, we provide an overview of how CDK controls meiotic events in both budding and fission yeast. We discuss mechanisms of CDK regulation through post-translational modifications and changes in the levels of cyclins. Finally, we highlight the similarities and differences in CDK regulation between the two yeast species. Since CDK and many meiotic regulators are highly conserved, the findings in budding and fission yeasts have revealed conserved mechanisms of meiotic regulation among eukaryotes. Keywords: meiosis; Cyclin-Dependent Kinase; CDK; cyclin; APC/C; budding yeast; fission yeast; chromosome segregation 1. Introduction Control of the eukaryotic cell cycle occurs through the modulation of phosphorylation states of proteins that trigger specific events. At the forefront of this phospho-regulation are the cyclin-dependent kinases (CDKs), whose oscillatory activity results in a large number of phosphorylations that change the activation state of their substrates [1,2].
    [Show full text]
  • Mitosis and Meiosis
    BIOLOGY 100 SOLUTIONS TO PROBLEMS MITOSIS AND MEIOSIS 1. If an organism has 15 pairs of homologous chromosomes, how many chromosomes will each daughter cell have after telophase of mitosis? In this same organism, how many chromosomes will each daughter cell have after telophase II of meiosis? n 2n n 2n 2n 2n n n Mitosis Meiosis If a cell has 15 pairs of chromosomes (n = 15), it has 30 chromosomes (2n = 30). At the end of mitosis, the two daughter cells will be exact copies of the original cell. Each daughter cell will have 30 chromosomes. At the end of meiosis II, each cell (i.e., gamete) would have half the original number of chromosomes, that is, 15 chromosomes. 2. How many DNA molecules are present in a chromosome of a cell in metaphase of mitosis? How many DNA molecules are present in a chromosome of a cell at metaphase II of meiosis? A chromosome in G1 of the cell cycle is composed of a very long molecule of double stranded DNA. Recall that DNA is replicated during the S phase of the cell cycle. Thus during metaphase of mitosis, each chromosome (i.e., each chromatid pair) will contain two molecules of double stranded DNA (one molecule per sister chromatid). The following diagram depicts the behavior of one homologous pair of chromosomes during mitosis. In a real cell, chromosomes would not be visible during interphase of the cell cycle. S phase mitosis telophase of mitosis During prophase I and metaphase I of meiosis, a chromosome consists of a tetrad (4 chromatids or 4 DNA molecules) and is reduced to two chromatids (2 DNA molecules) by the time metaphase II occurs.
    [Show full text]